1+ week, 6+ day ago (140+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. - The S&P 1500 Health Care Index advanced 4.0% in the third quarter, underperforming the S&P 500, which gained 8.1%. - Stock selection within biotechnology and health care providers & services, along with an overweight to biotechnology and an underweight to medtech added the most value relative to the Index. - Security selection within medtech, life sciences tools & services, and pharmaceuticals detracted from relative results during the period....

3+ week, 5+ day ago (123+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. - Eve Holding press release (EVEX): Q3 GAAP EPS of -$0.14 beats by $0.02. - Eve reported a net loss of $46.9 million in 3Q25, compared to $35.8 million in 3Q24. The increase in net loss in 3Q25 was primarily driven by higher Research & Development (R&D) expenses, which are costs...

2+ week, 5+ day ago (91+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. - Sunrise Communications AG press release (OTC:SNREY): Q3 Net loss of CHF4.4M More on Sunrise Communications AG...

3+ week, 3+ day ago (165+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. Earnings Call Insights: Amylyx Pharmaceuticals (AMLX) Q3 2025 - Justin Klee, Co-Founder, Co-CEO & Director, announced "Q3 was a quarter of progress as we continue to focus on our lead program, avexitide, in post-bariatric hypoglycemia or PBH" and highlighted that avexitide, with FDA breakthrough therapy designation, is showing high participant What impact does the LUCIDITY Phase III recruitment delay have on Amylyx Pharmaceuticals' avexitide launch timeline? How does Amylyx Pharmaceuticals" current financial position support ongoing clinical development?...

2+ week, 3+ day ago (106+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. - Pollard Banknote press release (PBL:CA): Q3 GAAP EPS of C$0.37 - Revenue reached C$156.3 million, up 2.0% from the third quarter of last year, a new quarterly record. More on Pollard Banknote...

2+ week, 5+ day ago (91+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. - Leveljump Healthcare press release (OTCPK:JMPHF): Q3 revenue of $4.84M (+8.8% Y/Y). More on Leveljump Healthcare...

3+ week, 3+ day ago (750+ words) " Zocilurtatug pelitecan (zoci, DLL3 ADC) (formerly ZL-1310) data presented at Triple Meeting in October continues to demonstrate first- and best-in-class potential, supporting the recent initiation of the global registrational study in 2L+ ES-SCLC " Advancing other high-potential global programs, including initiation of a global Phase 1 study for ZL-1503 (IL-13xIL-31R bispecific antibody) and a planned IND submission for ZL-6201 (LRRC15 ADC) by year-end 2025 " KarXT was recently included in China's national-level treatment guidelines, underscoring the urgent need for novel therapies in schizophrenia; launch preparations are underway " Total revenues grew 14% y-o-y to $116.1 million in the third quarter of 2025, operating loss improved by 28% y-o-y to $48.8 million, and by 42% to $28.0 million on an adjusted basis1; revising total revenue guidance for the full year 2025 to at least $460 million Conference call and webcast today, November 6, 2025, at 8:00 a.m. ET (9:00 p.m. HKT) SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Zai Lab Limited (ZLAB) (NASDAQ: ZLAB; HKEX: 9688) today announced financial…...

3+ week, 3+ day ago (111+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. How is Apyx Medical's AYON Body Contouring System impacting financial results? What is Apyx Medical's updated revenue outlook for 2025 and its key drivers? How does management view market demand and growth opportunities for Surgical Aesthetics?...

2+ week, 4+ day ago (113+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. Profound Medical (PROF) has entered into an exclusive distribution and supply agreement for its TULSA-PRO and Sonalleve technologies in Saudi Arabia with Al Faisaliah Medical Systems, it said on Wednesday, sending the stock 5% higher in early trading....

4+ day, 21+ hour ago (121+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. - Hims & Hers Health, Inc. (HIMS) presents a compelling risk-reward profile as bearish sentiment and regulatory concerns appear fully priced into the stock. - The upcoming Zava acquisition and potential regulatory changes could further boost HIMS's international presence and revenue, with DCF-based valuations suggesting significant upside....